Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme - MacDonald, M R; Petrie, M C; Varyani, F (Eur Heart J, 2008)
et al.